Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 437 (TSX: $FAF.TO)
(OTC: $EDXC) (CSE: $XCX.C) (TSX:
$VIVO.TO)
Delta, Kelowna, BC, July 7, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at http://www.investorideas.com/news/2020/cannabis-potcasts/07071FAF-EDXC-XCX-VIVO.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Fire
& Flower Holdings Corp. and its wholly-owned subsidiary Fire &
Flower Inc. (TSX: FAF) (OTCQX: FFLWF), announced the openings of its first two
cannabis retail stores adjacent to Circle K locations in the province of
Alberta.
Through this initiative, Fire &
Flower is expected to benefit from high traffic Circle K locations to deliver
an unprecedented level of convenience to cannabis customers, maximizing the
benefit of the Spark PerksTM program and Spark FastlaneTM online ordering
services at conveniently located stores.
The two stores in Calgary and Grande
Prairie are expected to be the first of additional opportunities to co-locate
cannabis retail stores in the future. The co-located stores will be owned and
operated by Fire & Flower and are separate from the adjacent Circle K in
accordance with all applicable regulations. It is anticipated that the Grande
Prairie store will open the week of July 6, 2020 and it is anticipated the
Calgary store will open the week of July 13, 2020.
Information on the co-located stores
will be available on the Fire & Flower website at www.fireandflower.com/locations/.
"As we continue to build our
relationship with Alimentation Couche-Tard, Fire & Flower is very pleased
to be embarking on this initiative together," shared Trevor Fencott, Chief
Executive Officer of Fire & Flower. "We believe that combining
convenient pickup locations with digital engagement offered by the Hifyre
platform and Spark Perks program presents our customers with a differentiated
value proposition in an increasingly competitive cannabis retail market. This
approach to innovation in omni-channel and convenience-oriented cannabis retail
differentiates Fire & Flower and positions us well to capitalize on both
domestic and international opportunities."
Endexx®
Corporation (OTC: EDXC) announced the e-commerce launch of RubyBees™
Hemp Infused Honey. RubyBees™ is now available in 950mg and 120mg jars for
purchase on CBD Unlimited’s website.
Peter Boyer created RubyBees Hemp
Honey when he was first introduced to CBD Unlimited’s hemp-derived CBD, an
active ingredient derived directly from the hemp plant that exhibits soothing
properties, as a way to ease the symptoms of his daughter. Longtime Endexx
shareholder, Richard Steinhart, has long believed in the therapeutic benefits
of CBD and suggested Boyer consult his daughter’s doctor about trying CBD
sublingual oil alongside the medication she already takes for her cerebral
palsy and epilepsy.
“As a father with a special needs
daughter, I was searching for a way to help improve Ruby’s life. After working
with CBD Unlimited and using their hemp-derived isolate, the positive change in
Ruby’s everyday life was apparent. Utilizing honey as the delivery system and
implementing the knowledge of proper dosages provided by the CBDU team, the
tasty treat doubles as an effective way to enjoy the benefits of CBD. With
their expansive knowledge and expertise in the industry, working with CBD
Unlimited was a clear step in the right direction. We at RubyBees are eager and
excited to be a part of such an incredible industry and to be working with a
company focused on improving the lives of the people we care for,” commented Founder of RubyBees, Peter Boyer.
Great for coffee, tea, power drinks,
toast spread, or for cooking, RubyBees Hemp Honey products are made with clover
honey and infused with 10mg of hemp-derived isolate per serving while
containing zero percent THC, no gluten, and no GMO’s. RubyBees Hemp Honey is
also available in honey stick format, lab tested, and certified.
“We at CBD Unlimited are incredibly
grateful and excited to offer our CBD in a product from a company as inspiring
as RubyBees,” commented Todd Davis, CEO and Chairman of Endexx. “Whether the
product is used as a therapeutic treatment or as a pick-me-up snack, we are
confident that the RubyBees Hemp Honey will soon become a consumer favorite and
continue to make waves in the CBD industry.”
To purchase RubyBees Hemp Infused
Honey, please follow this link: https://www.cbdunlimited.com/our-products/rubybees-hemp-honey-950mg/
AMP
German Cannabis Group Inc. (CSE: XCX) announced further to its June 5, 2020 news
release that The Office of Medical Cannabis ("OMC"), the government
organization of the Netherlands for distribution of medical cannabis products,
has notified AMP that it will resume exports of EU-GMP medical cannabis to
Germany. The OMC will deliver 3,000 grams per month to each German importer due
to the high demand and restricted supply currently available for Germany.
AMP has ordered Bedrocan
International branded products to be exported by OMC on a monthly basis
beginning July 2020. AMP has received all the required licenses to import
irradiated cannabis flowers from the Dutch and German government authorities.
Dr. Stefan Feuerstein, Director and
President of AMP, commented: "All pieces of the puzzle have come together
with the start of our first import. We will be booking our first revenue from
the sale of our Bedrocan products this month and hope to receive a higher
amount from the Netherlands in August 2020. We are also on track to sign a
definitive supply agreement with a Canadian supplier and will be adding
pharmaceutical distribution partners that focus on medical cannabis exclusively
to our distribution network covering Germany. Our next step is to increase
import volumes from Canada in conjunction with developing AMP's medical
cannabis brands for the German market."
VIVO
Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF), a leading provider of premium
cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited,
ABcann Medicinals Inc. and Harvest Medicine Inc., who provided an update on its global medical
business, which operates in Canada, Germany and Australia.
"One of our top strategic
priorities is to focus on the global medical cannabis market, directly
servicing tens of thousands of patients and investing in product development
initiatives that prioritize high-quality novel products," said Barry
Fishman, CEO of VIVO. "We've
recently made significant progress on a number of key initiatives, which will
help solidify our market presence as a company that is committed to delivering
solutions for patients and healthcare professionals on an international
scale."
VIVO believes that significant
growth in medical cannabis utilization will be driven by several factors
including:
1. Accelerating legalization of
medicinal cannabis globally
2. Mounting real-world and clinical
evidence of therapeutic benefits
3. Increasing clinician adoption of
medical cannabis as a viable therapeutic option
4. Growing reimbursement by
governments and third-party payors
5. Improving patient and healthcare
practitioner awareness, education and access
6. Introducing new medical-grade,
precise-dosed, stable formulations
7. Removing the sales tax on medical
cannabis in Canada
The Company is pleased to announce
several initiatives that advance the Company's impact within the global medical
cannabis market.
Shoppers
Drug Mart Partnership
VIVO has entered into both a product
supply agreement and a clinic services agreement with Medical Cannabis by
Shoppers™. As previously announced,
VIVO's two licensed producers will offer a broad portfolio of Canna Farms™ and
Beacon Medical™ branded medical cannabis products through the Medical Cannabis
by Shoppers™ online sales platform, including its latest Cannabis 2.0 offerings
such as chocolates and extracts making these products accessible to Medical
Cannabis by Shoppers™ patients across Canada.
Under the terms of the clinic
services agreement, VIVO's subsidiary, Harvest Medicine, will provide cannabis
education services to patients who are appropriate candidates for
cannabinoid-based products available from Medical Cannabis by Shoppers™ and
provide consulting services to its Cannabis Care team.
Launch
of Beacon Medical Oils in Australia
VIVO's subsidiary, Beacon Medical
Australia, has entered into a supply agreement with MediPharm Labs Australia to
purchase pharmaceutical quality (GMP certified) cannabis oils for the
Australian market.
As previously announced, under the
agreement MediPharm Labs Australia will supply its full range of GMP-certified,
formulated CBD and THC cannabis oils to Beacon Medical Australia for further
distribution under the Beacon Medical branding.
The addition of cannabis oils to Beacon's Australian portfolio is an
important step towards capturing market share in Australia's growing medical
cannabis market.
Veterans
House Partnership
VIVO has entered into a
collaboration agreement with Veterans House ("Veterans House"), under which the Company will provide
sponsorship and support to joint programs for Canadian Armed Forces veterans.
Veterans House is a federally registered non-profit organization that provides
veterans suffering from mental illness and operational stress injuries such as
post-traumatic stress disorder, with access to counseling and peer support
programs.
"Canna Farms is a long-standing
supporter of veterans, providing access to leading medical cannabis products
and programs," said Fabian Henry, Senior Director of Operations at Veterans
House. "The team at VIVO has shown an ongoing commitment to Canadian
veterans and we look forward to working more closely together to serve this
community."
"We are proud to be associated
with Veterans House," said Mr. Fishman. "Our veterans have dedicated
their lives to defending the rights and freedoms we have in Canada. We are
honoured to play an important role in enhancing the quality of life for our
veterans."
Medical
Product Line Expansion
VIVO also introduced softgel
capsules, with several cannabinoid concentrations
available, through its Canna Farms
on-line medical marketplace in the coming weeks. Softgel capsules provide
patients with a convenient format to ingest cannabis in a precisely dosed
format.
The introduction of softgels follows
the successful launch of VIVO's Cannabis 2.0 product offerings (including
chocolates and extracts) into the Canadian medical market, increasing choice
for the Company's more than 20,000 registered patients.
The Canna Farms store now carries
six leading medical brands including GTEC, Aqualitis and Pure Sunfarms.
"Our web-based medical store continues to be a key point of connection for
Canadian patients to conveniently access medical cannabis products," said
Daniel Laflamme, President of Canna Farms. "Having a consistent supply of
medical products has been an industry-wide concern and we continue to enhance
our manufacturing processes and relationships with other established
high-quality LP partners, to supply our medical patients with a wide range of
product options."
Product
Development Progress
VIVO moved into the next stage of
product innovation with partner Pharmascience Inc., a global pharmaceutical
company based in Montreal, for the development of a line of specific medical cannabis
formulations produced under pharmaceutical quality standards intended to
maximize the benefit to patients.
"Healthcare professionals and
patients are increasingly searching for precisely-controlled, high-quality,
standardized dosage forms of medical cannabis. VIVO has invested in several
product development projects with proven partners experienced in formulating
complex medical products," stated Mr. Fishman.
EU-GMP
Follow-up Audit Completed
A follow-up EU-GMP audit was
recently completed at VIVO's ABcann Medicinal facility in Napanee. This is an
important step towards EU GMP-certification and is a requirement to export
medical cannabis products from Canada for sale in Germany and other European
countries.
Real-World
Evidence Collaboration
The Company entered into a
partnership with privately held Reformulary Group, an innovative healthcare
company dedicated to helping Canadians make sense of medicine (prescription
drugs and medical cannabis). VIVO has agreed to provide clinical support,
through the Company's Harvest Medicine clinics, to patients who access
Reformulary Group's Cannabis Standard™ platform. Cannabis Standard is an
ecosystem of expert recommendations, patient-powered tools, and independent
information to help Canadians and healthcare professionals make smarter, more
informed decisions about choosing medical cannabis.
"Cannabis Standard™ applies the
same formula that we've used so successfully on the prescription medication
side. We gathered a panel of independent medical experts, conducted a
comprehensive review all of the available evidence globally, and created
user-friendly tools to help Canadians navigate the medical cannabis
space," said Helen Stevenson, Reformulary Group founder and CEO. "At
its core, Cannabis Standard™ is about helping patients benefit from and
contribute to the growing base of medical cannabis research, and we look
forward to working closely with the team at VIVO to advance patient
outcomes."
VIVO has also engaged Strainprint
Technologies™, a leader in cannabis data and analytics, to examine real-world
evidence of its products, linking utilization and efficacy for several of the
leading indications treated with medical cannabis from thousands of patients.
This evidence is being used by healthcare professionals to assist in
determining optimal treatment options and by patients to help navigate their
medical cannabis journey. VIVO is the first Canadian LP to provide this
valuable information on its products to key stakeholders.
Patient
Support Under COVID-19
Health Canada recently announced
that due to COVID-19, it is temporarily extending the expiry date of
registrations by six months for patients who are having difficulty accessing
their health care prescriber to obtain a new medical document.
Since Harvest Medicine temporarily
moved its entire clinic operations to telemedicine in late Q1 2020, the
feedback from patients and prescribing clinicians adapting to virtual visits
has been overwhelmingly positive.
"Not only has there been no
lapse in ongoing care for our patients during COVID-19, but our dedicated team
was able to scale up to meet increased patient demand for visits on our HMED Connect
mobile application platform which have more than tripled during the
pandemic," stated Carole Chan, President of Harvest Medicine. "We
understand the importance of in-person consultations for certain patient
populations, and we will continue to offer this option when clinics re-open in
the near future with enhanced protocols to keep patients and staff safe."
VIVO is confident that it will
benefit from Health Canada's recent announcement and Harvest Medicine's ability
to continue to provide high-quality patient services during COVID-19.
Product
Identification Enhancement
VIVO, through its global Beacon
Medical™ brand has simplified its consumer-facing product naming conventions
and added Product Identification Numbers (PINs) to its core Canadian offering
to better support doctors, pharmacists and patients in navigating medical
cannabis. "Introducing PINs will enable Canadian insurers to more easily
navigate our products," commented Matt Patterson, Vice President of
Medical Strategy.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
